Catalent Inc. (CTLT) News, Articles, Events & Latest Updates
Find Catalent Inc. (CTLT) news, corporate events, press releases, latest company updates and headlines
Catalent (CTLT) Stock Price, News & Analysis - MarketBeat
Dec 18, 2024 · Should You Buy or Sell Catalent Stock? Get The Latest CTLT Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal …
Oct 24, 2024 · Shares of Catalent CTLT lost 0.9% on Oct. 23 with the rise in uncertainty related to its acquisition by Novo Holding following a report from Reuters on opposition from several large pharma...
CTLT News Today | Why did Catalent stock go up today?
Dec 18, 2024 · Catalent (NYSE:CTLT) Sets New 12-Month High - Here's What Happened. Toronto Dominion Bank lowered its position in Catalent, Inc. (NYSE:CTLT - Free Report) by 76.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Catalent Stockholders Approve Transaction with Novo Holdings
May 29, 2024 · Based on the preliminary count of the voting results from today’s Special Meeting, Catalent stockholders voted to approve the transaction with 99.2% of ballots cast in favor of the proposed...
Catalent, Inc. (CTLT) Stock Price, Quote & News - Stock Analysis
Dec 17, 2024 · Get the latest Catalent, Inc. (CTLT) stock price quote with news, financials and other important investing information.
Catalent Inc. (CTLT) Stock Price Today, Quote, Latest Discussions ...
Track Catalent Inc. (CTLT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.
Catalent, Inc. Common Stock (CTLT) News Headlines | Nasdaq
Find the latest news headlines from Catalent, Inc. Common Stock (CTLT) at Nasdaq.com.
All News for CTLT : Catalent - Zacks.com - Zacks Investment Research
Dec 6, 2024 · Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Novo Holdings Completes $16.5 Billion Acquisition of Catalent | News …
Dec 19, 2024 · The Private Equity and Public M&A teams advised Novo Holdings A/S (“Novo Holdings”) on the completion of its acquisition of Catalent, Inc. (NYSE: CTLT) in an all-cash transaction with a total enterprise value of approximately $16.5 billion. In connection with the transaction, Novo Holdings will sell three of Catalent’s nearly 50 global sites to Novo Nordisk A/S (“Novo Nordisk”).
- Some results have been removed